Profusa Announces 1-for-25 Reverse Stock Split
Profusa, Inc., a digital health company specializing in continuous biochemical monitoring technology, has filed for a 1-for-25 reverse stock split of its common stock, effective July 7, 2026. This action will consolidate every 25 shares into one share, reducing outstanding shares from about 13.2 million to approximately 530,000, with no change to p…